![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
ACR 2020 | Richard Furie discusses the LILAC trial (Medicine Matters rheumatology) View |
![]() |
Richard Furie, MD, Talks About Anifrolumab Treatment in Patients with SLE (DocWire) View |
![]() |
Dr. Richard Furie Discusses Lupus and Phase 3 BLISS-LN Clinical Trial (To Be Frank) View |
![]() |
AstraZeneca - FDA Approval of Saphnelo™ (anifrolumab) For Lupus Erythematosus (SLE) (HPR) View |
![]() |
Trial Drug Shows Promise Against Lupus (Health Is Wealth) View |
![]() |
Prof. Richard Alan Furie, EULAR 2017: Eine spannende Ära für die SLE-Forschung (esanum) View |
![]() |
Rheumatoid Arthritis (The Family Eye Clinic) View |
![]() |
ABP 980, a biosimilar antibody for trastuzumab (ecancer) View |
![]() |
Results from the LILAC study of ABP 980 with trastuzumab for HER2+ early breast cancer (ecancer) View |
![]() |
personalized immunomonitoring and treatment in lupus nephritis era62017 (abd hamed) View |